Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

Don't buy big here and don't buy all at once, but it's not too late to ride this bull to profits, says Jim Cramer.

Jim Cramer is bullish on Exxon, Chevron, Cimarex Energy, Skechers USA, and Halozyme Therapeutics.

Jim Cramer says President Trump has been a great salesman, but when we look at winning stocks, it's the strong CEOs who are driving success.

In this sometimes fickle market, supply and demand are still at play.

Pharma giant aims to develop cancer drug delivery technology. Halozyme shares are up more than 16% in pre-market trading.

Universal Studios has begun construction on Epic Universe, its third theme park planned for Florida.

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

The Tesla CEO has put his offer for Twitter back on the table. And as rich as he is, investors are worried.